Ovid Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 144.11K shares.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 123.02K shares.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 60.37K shares.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 60.37K shares, a 75.66% decline from fiscal 2024.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 248.02K shares, a 69.48% increase from fiscal 2023.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 146.35K shares, a 473.50% increase from fiscal 2022.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 25.52K shares, a 91.16% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 144.11K shares 10-Q · filed 2026-08-13 | 327.50K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 123.02K shares 10-Q · filed 2026-05-12 | 183.40K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 60.37K shares derived: 10-K 12 month − 3 quarters · filed 2026-03-18 | 60.37K shares 10-K · filed 2026-03-18 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-12 | 0.00 shares derived: sum of 4 quarters · filed 2026-03-18 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-03-18 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-13 | 171.12K shares derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 248.02K shares 10-K · filed 2026-03-18 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 259.46K shares derived: sum of 4 quarters · filed 2025-03-11 |
| 2024-06-30 | 171.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 303.29K shares derived: sum of 4 quarters · filed 2025-03-11 |
| 2024-03-31 | 76.91K shares 10-Q · filed 2024-05-14 | 213.63K shares derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-12-31 | 11.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 146.35K shares 10-K · filed 2025-03-11 |
| 2023-09-30 | 43.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 134.91K shares derived: sum of 4 quarters · filed 2024-03-08 |
| 2023-06-30 | 81.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | 100.70K shares derived: sum of 4 quarters · filed 2024-03-08 |
| 2023-03-31 | 9.63K shares 10-Q · filed 2023-05-05 | 21.39K shares derived: sum of 4 quarters · filed 2024-03-08 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | 25.52K shares 10-K · filed 2024-03-08 |
| 2022-09-30 | 9.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 57.20K shares derived: sum of 4 quarters · filed 2023-03-13 |
| 2022-06-30 | 2.14K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 247.90K shares derived: sum of 4 quarters · filed 2023-03-13 |
| 2022-03-31 | 13.75K shares 10-Q · filed 2022-05-10 | 291.88K shares derived: sum of 4 quarters · filed 2023-03-13 |
| 2021-12-31 | 31.69K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 288.52K shares 10-K · filed 2023-03-13 |
| 2021-09-30 | 200.32K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 308.79K shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2021-06-30 | 46.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 149.87K shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2021-03-31 | 10.40K shares 10-Q · filed 2021-05-13 | 175.78K shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-12-31 | 51.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 165.38K shares 10-K · filed 2022-03-15 |
| 2020-09-30 | 41.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | |
| 2020-06-30 | 72.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-15 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | 15.74K shares 10-K · filed 2020-03-11 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 20.06K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-06-30 | 13.99K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 20.06K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-03-31 | 1.75K shares 10-Q · filed 2018-05-08 | 6.07K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-12-31 | 4.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 4.32K shares 10-K · filed 2019-03-07 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-06-13 | |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-03-29 | |
| 2015-12-31 | 0.00 shares 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |